Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 18, 2013
[Current state and vision of the development of new antipsychotic drugs]Yoshiteru Takekita, Toshihiko Kinoshita
Frontiers in Psychiatry|April 3, 2026
Treatment continuation and factors associated with discontinuation with 3-month paliperidone palmitate in patients with schizophrenia: a <i>post hoc</i> analysis of post-marketing surveillance data in JapanYoshiteru Takekita, Natsuko Tokushige, Yosuke Saga
The South African Journal of Psychiatry : SAJP : the Journal of the Society of Psychiatrists of South Africa|October 4, 2024
Lithium-induced cognitive dysfunction assessed over 1-year hospitalisation: A case reportYuji Murase, Masaki Kato, Toshihiko Kinoshita, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 31, 2016
[Vascular dementia: an update]Masafumi Yoshimura, Keiichiro Nishida, Yoshiteru Takekita, et al.
Neuropsychiatric Disease and Treatment|December 10, 2020
Rehospitalization Risk of Receptor-Affinity Profile in Antipsychotic Drug Treatment: A Propensity Score Matching Analysis Using a Japanese Employment-Based Health Insurance DatabaseYoshiteru Takekita, Sachie Inoue, Kenji Baba, et al.
Neuropsychopharmacology Reports|May 26, 2023
Long-term safety and efficacy of sublingual asenapine for the treatment of schizophrenia: A phase III extension study with follow-up for 52 weeks (P06125)-Secondary publicationToshihiko Kinoshita, Yoshiteru Takekita, Shuichi Hiraoka, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|January 26, 2023
Efficacy of Asenapine in Drug-resistant Psychotic Patients with Dopamine Supersensitivity Psychosis: Two CasesNobuhisa Kanahara, Hiroshi Kimura, Toshihiko Kinoshita, et al.
Heliyon|October 27, 2023
Characteristics of persistent depression in the long-term: Randomized controlled trial and two-year observational studyYosuke Koshikawa, Ai Onohara, Masataka Wakeno, et al.
Frontiers in Psychiatry|May 6, 2026
Postmarketing surveillance of elobixibat for patients with chronic constipation and concomitant schizophrenia or depression in JapanYoshiteru Takekita, Minami Umeyama, Mie Iwaida, et al.
Neuropsychopharmacology Reports|October 21, 2024
Association between treatment response and dose of blonanserin transdermal patch in patients with acute schizophrenia: A post hoc cluster analysis based on baseline psychiatric symptomsYoshiteru Takekita, Yuji Matsumoto, Takahiro Masuda, et al.
Pageof 6